SGLT2 Inhibitors Decrease Overhydration and Proteasuria in Patients with Chronic Kidney Disease: A Longitudinal Observational Study.
Anja SchorkMarie-Luise EberbachBernhard N BohnertMatthias WörnDavid J HeisterFelix EisingerElisabeth VogelNils HeyneAndreas L BirkenfeldFerruh ArtuncPublished in: Kidney & blood pressure research (2024)
SGLT2 inhibitors reduce OH in patients with CKD, which is pronounced in the presence of high albuminuria, glucosuria, and urinary aprotinin-sensitive protease activity.
Keyphrases